Fact CheckerSign in

NCT05597410Recruiting

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Source: ClinicalTrials.gov · Last updated 28 Oct 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are: * cognitive changes of subjects at high risk of AD as ageing; * environmental and behavioral factors affecting AD incidence.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3418 (estimated)
First submitted
12 Oct 2022
Start date
1 Mar 2022
Primary completion date
Mar 2029
Lead sponsor
Ruijin Hospital
NCT number
NCT05597410

What you commit to

  • Study type: Observational
  • Planned participants: 3418
  • From 1 Mar 2022 to the primary completion date, Mar 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • other diseases which could cause cognitive decline, e.g. cerebrovascular diseases, Creutzfeldt-Jakob disease and Parkinsons disease;
  • history of psychological disorders (according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition);
  • uncorrectable visual or auditory impairment that hampers the completion of related examination.

Other

  • Individuals will be excluded if they have:
  • pre-menopausal women will also be excluded.

Who the study is looking for

  • the AD diagnostic criteria of probands meet the 2011 National Institute on Aging - Alzheimer's Association framework, and participants are the first-degree relatives (including parents, children and siblings of the same father and mother) of the proband;
  • not patients with dementia;
  • ≥ 50 years, males and females;
  • subjects have lived in Shanghai for more than 1 year and have no plan to move out of Shanghai within 5 years;
  • subjects are able to complete investigation, physical examination, imaging examination and biological specimen collection.

Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.